Validation of a nicotine vapor self-administration model in rats with relevance to electronic cigarette use
- 16 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 45 (11), 1909-1919
- https://doi.org/10.1038/s41386-020-0734-8
Abstract
The debate about electronic cigarettes is dividing healthcare professionals, policymakers, manufacturers, and communities. A key limitation in our understanding of the cause and consequences of vaping is the lack of animal models of nicotine vapor self-administration. Here, we developed a novel model of voluntary electronic cigarette use in rats using operant behavior. We found that rats voluntarily exposed themselves to nicotine vapor to the point of reaching blood nicotine levels that are similar to humans. The level of responding on the active (nicotine) lever was similar to the inactive (air) lever and lower than the active lever that was associated with vehicle (polypropylene glycol/glycerol) vapor, suggesting low positive reinforcing effects and low nicotine vapor discrimination. Lever pressing behavior with nicotine vapor was pharmacologically prevented by the α4β2 nicotinic acetylcholine receptor partial agonist and α7 receptor full agonist varenicline in rats that self-administered nicotine but not vehicle vapor. Moreover, 3 weeks of daily (1 h) nicotine vapor self-administration produced addiction-like behaviors, including somatic signs of withdrawal, allodynia, anxiety-like behavior, and relapse-like behavior after 3 weeks of abstinence. Finally, 3 weeks of daily (1 h) nicotine vapor self-administration produced cardiopulmonary abnormalities and changes in α4, α3, and β2 nicotinic acetylcholine receptor subunit mRNA levels in the nucleus accumbens and medial prefrontal cortex. These findings validate a novel animal model of nicotine vapor self-administration in rodents with relevance to electronic cigarette use in humans and highlight the potential addictive properties and harmful effects of chronic nicotine vapor self-administration.Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (1F31DA047113-01)
- Tobacco-Related Disease Research Program (27IR-0047)
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA022977, AA006420)
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
This publication has 68 references indexed in Scilit:
- Animal Models of Nicotine Exposure: Relevance to Second-Hand Smoking, Electronic Cigarette Use, and Compulsive SmokingFrontiers in Psychiatry, 2013
- The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: Dual role in nicotine addiction and lung cancerProgress in Neurobiology, 2010
- Varenicline blocks nicotine intake in rats with extended access to nicotine self-administrationPsychopharmacology, 2010
- Exposure to chronic intermittent nicotine vapor induces nicotine dependencePharmacology Biochemistry and Behavior, 2010
- Neurobiology of nicotine dependencePhilosophical Transactions B, 2008
- Gestational nicotine exposure reduces nicotinic cholinergic receptor (nAChR) expression in dopaminergic brain regions of adolescent ratsEuropean Journal of Neuroscience, 2005
- The pathophysiology of cigarette smoking and cardiovascular disease: An updateJournal of the American College of Cardiology, 2004
- Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the MouseThe Journal of pharmacology and experimental therapeutics, 2003
- Nicotine maintains robust self-administration in rats on a limited-access schedulePsychopharmacology, 1989
- Nicotine as a reinforcer in human subjects and laboratory animalsPharmacology Biochemistry and Behavior, 1983